
HealthQuest Capital
Description
HealthQuest Capital is a prominent growth equity firm based in Redwood City, California, specializing in the healthcare sector. Established in 2013, the firm focuses on investing in commercial-stage companies that offer innovative products, services, or technologies with proven market traction and significant growth potential. Their investment thesis centers on identifying businesses that are poised to transform healthcare delivery, improve patient outcomes, and reduce costs across various sub-sectors, including medical devices, diagnostics, digital health, and tech-enabled services.
HealthQuest Capital employs a hands-on approach, leveraging its deep industry expertise and extensive network to support portfolio companies through strategic guidance, operational improvements, and access to key industry relationships. The firm's commitment to the healthcare ecosystem is underscored by its impressive fundraising track record, having raised over $2 billion in capital across multiple funds since its inception. This substantial capital base allows them to make meaningful investments in companies that have already achieved commercial success and are ready to scale.
In a notable development, HealthQuest Capital announced the close of its fifth fund, HealthQuest Partners V, L.P., in early 2023, securing $675 million in commitments. This fund reinforces their strategy of targeting high-growth healthcare companies that are beyond the early-stage venture phase but require significant capital to accelerate their market penetration and expansion. The firm typically seeks companies with established revenues and a clear path to profitability, aiming to provide the necessary resources for these businesses to achieve their next phase of growth and ultimately deliver strong returns for their limited partners.
Investor Profile
HealthQuest Capital has backed more than 52 startups, with 6 new investments in the last 12 months alone. The firm has led 30 rounds, about 58% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada, United Kingdom.
- Strong thematic focus on Health Care, Medical Device, Health Diagnostics.
- Led 5 rounds in the past year.
- Typical check size: $25M – $75M.
Stage Focus
- Series Unknown (31%)
- Series C (21%)
- Series B (15%)
- Series D (6%)
- Series F (6%)
- Post Ipo Equity (4%)
- Private Equity (4%)
- Series A (4%)
- Series E (2%)
- Series G (2%)
Country Focus
- United States (87%)
- Canada (6%)
- United Kingdom (6%)
- South Korea (2%)
Industry Focus
- Health Care
- Medical Device
- Health Diagnostics
- Medical
- Biotechnology
- Information Technology
- Software
- Wellness
- Mhealth
- Clinical Trials
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.